Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating switching from Zoladex monthly or quarterly to Eligard semiannual in men with prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Eligard (leuprolide acetate)
• Zoladex (goserelin)

Snippet

Sponsor: Zodiac Produtos Farmaceuticos S.A. | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED